Literature DB >> 16281435

Barriers to success for an evidence-based guideline for chronic obstructive pulmonary disease.

B J Smith1, K Dalziel, H J McElroy, R E Ruffin, P A Frith, K A McCaul, F Cheok.   

Abstract

OBJECTIVES: To evaluate 1) barriers to clinical guideline use and 2) the relationship between guideline use and inpatient outcomes in chronic obstructive pulmonary disease (COPD).
METHODS: 1) Four focus groups of specific health professions (n = 30), from three metropolitan hospitals, and interview of 99 medical officers (MOs), linked to 349 admissions, both guided by behavioural modelling theory; 2) association between guideline use and patient outcomes (length of hospital stay > or = 14 days, and readmission within 28 or 90 days) was evaluated in a cohort of 405 COPD patients.
RESULTS: 1) In focus groups, nurses and allied health professionals emphasized facilitation issues including paperwork duplication and time limitations as barriers, but considered improved patient care outcomes as the major guideline use determinant. There were similar findings in junior MOs (nonconsultants) by both focus group and interview, with the addition of a need for a sense of ownership. Senior MOs (consultants) greatly emphasized sense of ownership. Barriers to guideline use varied between types of units. Behavioural modelling explained 49% of the variation in intention to use the guideline for MOs. For nonconsultants, habit and intention were significantly associated with extent of guideline use. 2) Patient outcomes: guideline use was not associated with length of stay or readmission.
CONCLUSIONS: 1) Guideline implementation should address issues relevant to different health professions, units and seniority of profession. 2) Guideline use was not associated with reductions in readmission or length of stay.

Entities:  

Mesh:

Year:  2005        PMID: 16281435     DOI: 10.1191/1479972305cd075oa

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  8 in total

1.  Pulmonary rehabilitation: overwhelming evidence but lost in translation?

Authors:  Kylie Johnston; Karen Grimmer-Somers
Journal:  Physiother Can       Date:  2010-10-18       Impact factor: 1.037

2.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

3.  A qualitative study of individuals at risk for or who have chronic obstructive pulmonary disease: what do they understand about their disease?

Authors:  Donna R Parker; Roberta E Goldman; Charles B Eaton
Journal:  Lung       Date:  2008-05-08       Impact factor: 2.584

4.  Differences in COPD-related readmissions to primary and secondary care hospitals.

Authors:  Pekka Lampela; Olli Säynäjäkangas; Jari Jokelainen; Timo Keistinen
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

5.  Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners.

Authors:  Kylie N Johnston; Mary Young; Karen A Grimmer-Somers; Ral Antic; Peter A Frith
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-12-06

6.  Developing a questionnaire to identify perceived barriers for implementing the Dutch physical therapy COPD clinical practice guideline.

Authors:  Philip J van der Wees; Cor A M Zagers; Sara E de Die; Erik J M Hendriks; Maria W G Nijhuis-van der Sanden; Rob A de Bie
Journal:  BMC Health Serv Res       Date:  2013-05-01       Impact factor: 2.655

7.  Which chronic obstructive pulmonary disease care recommendations have low implementation and why? A pilot study.

Authors:  Kylie Johnston; Karen Grimmer-Somers; Mary Young; Ral Antic; Peter Frith
Journal:  BMC Res Notes       Date:  2012-11-23

8.  A work force model to support the adoption of best practice care in chronic diseases - a missing piece in clinical guideline implementation.

Authors:  Leonie Segal; Kim Dalziel; Tom Bolton
Journal:  Implement Sci       Date:  2008-06-18       Impact factor: 7.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.